August 2023 Issue Table Of Contents

From The Editor

• A Measure Of Improvement Needed

Feature Articles

• Vincerx Pharma: Finding Strength In Symbiosis
• Novo Nordisk Returns To Growth, With Growing Pains

Companies To Watch

• Ventoux Biosciences

Industry Research

• Cell & Gene Therapies Manufacturing Market Outlook

Podcast Summary

• The Immigrant Approach To Biotech Formation

Inside The Industry

• 3 Lessons For Building Biostatistics++ Teams In Pharma
• Cost Of Quality: Worth Every Cent In Biopharma Manufacturing
• Why Counterfeit And Substandard Antibiotics Matter To The Pharma Industry
• Market Dislocations And Their Impact On Life Sciences Debt Financing
• Going European — Affimed’s American CBO
• Why ERGs Are Critical To A Company’s Future Success
• Which CDMO Traits Predict Sponsor Loyalty When Outsourcing Small Molecule API?
• State Scrutiny Of Drug Pricing Intensifies With Rise Of PDABs
• Should My Startup Buy Or Produce The Proteins We Use?
• Understanding Data Collection And Management In DCTs
• Where Has All The Talent Gone In The U.K.?

Industry Leader

• Staff Burnout — A Threat To Clinical Operations Output
• Adjusting Industry Expectations of Investigators: Why It Matters

Leadership Lessons

• How To Be A Leader Employees Don't Leave

Ask The Board

• In These Times Of Increasingly Unpredictable And Lurching Change, What Skills Will Separate Out Next-Gen CEOs?
• How Can Drug Developers Work Together With The FDA To Maximize The Value Of A Clinical Trial Protocol?